VisionPoint Advisory Group LLC Sells 23,943 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

VisionPoint Advisory Group LLC trimmed its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 97.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 611 shares of the exchange traded fund’s stock after selling 23,943 shares during the period. VisionPoint Advisory Group LLC’s holdings in SPDR S&P Biotech ETF were worth $56,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also bought and sold shares of XBI. Golden State Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $29,000. Avior Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 393.6% in the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after acquiring an additional 307 shares during the period. Tidemark LLC grew its position in shares of SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after buying an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new position in SPDR S&P Biotech ETF during the 3rd quarter valued at $40,000. Finally, Bank of Jackson Hole Trust bought a new position in SPDR S&P Biotech ETF in the fourth quarter worth about $43,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $91.70 on Friday. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The company has a market capitalization of $6.99 billion, a PE ratio of 11.47 and a beta of 1.11. The firm’s 50-day moving average price is $91.36 and its 200-day moving average price is $95.97.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.